![Peter Davies](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Davies
Directeur/Membre du Conseil chez
Bionomics Ltd.
Fortune : 669 $ au 31/05/2026
Profil
Peter Miles Winston Davies is currently an Independent Non-Executive Director at Bionomics Ltd. since 2021, an Independent Non-Executive Director at Neuphoria Therapeutics, Inc. since 2024, and Chief Business Officer at Leaf4life, Inc. Formerly, Mr. Davies was Managing Director at Apeiron Investment Group Ltd. from 2021 to 2022.
Education includes graduation from The University of Edinburgh.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0 % | 20/01/2026 | 126 ( 0 % ) | 669 $ | 31/05/2026 |
Postes actifs de Peter Davies
| Sociétés | Poste | Début |
|---|---|---|
Bionomics Ltd.
 Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Directeur/Membre du Conseil | 01/07/2021 |
Leaf4life, Inc. | Corporate Officer/Principal | - |
Anciens postes connus de Peter Davies
| Sociétés | Poste | Fin |
|---|---|---|
Apeiron Investment Group Ltd.
 Apeiron Investment Group Ltd. Investment ManagersFinance Apeiron Investment Group invests in both public and private companies located across the globe primarily in the United States. The firm targets companies operating across a broad range of sectors and industries. It participates in pre-seed, seed, early, later and growth stage transactions. The firm invests in funds. It also acquires minority interest. | Private Equity Investor | 01/01/2022 |
Formation de Peter Davies
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Health Technology |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apeiron Investment Group Ltd.
Apeiron Investment Group Ltd. Investment ManagersFinance Apeiron Investment Group invests in both public and private companies located across the globe primarily in the United States. The firm targets companies operating across a broad range of sectors and industries. It participates in pre-seed, seed, early, later and growth stage transactions. The firm invests in funds. It also acquires minority interest. | Finance |
Leaf4life, Inc. | Commercial Services |
